Skip to content

Digital Intervention Postoperative Protocol

A Digital Intervention Protocol to Enhance Recovery After Head and Neck Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04828109
Enrollment
80
Registered
2021-04-01
Start date
2021-10-25
Completion date
2022-09-01
Last updated
2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otolaryngologic Disorder, Pain, Postoperative, Surgery

Brief summary

Postoperative recovery after head and neck surgery is complex, and often requires utilization of narcotic medications. The aim of this study is to evaluate reduction in pain and use of opioid medications through Virtual Reality (VR) and Fitbit wearable activity devices.

Detailed description

Enhanced Recovery After Surgery (ERAS) protocols were introduced as a method to optimize perioperative patient care. Narcotic medications are frequently utilized in postoperative care, but these have risks including sedation or dependence. Non-pharmacologic measures for postoperative pain control may help limit the need for opioids in postoperative pain control. Early mobilization is also important after surgery, however postoperative mobility is rarely monitored and relies on subjective reports. The investigators will seek to examine the implementation of an ERAS protocol using VR and Fitbit wearable activity devices on postoperative recovery after head and neck surgery. This is a prospective, 4-arm, randomized controlled trial.

Interventions

DEVICEVirtual Reality

Use of any virtual reality experiences available

DEVICEFitbit

Use of a Fitbit wearable activity device to track daily step goals.

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* English speaking * 18 to 89 years of age. * Planned to undergo major head and neck surgery OHSU with an expected length of stay of two days or more. * Ability to understand goals of the study and willingness to sign a written informed consent document.

Exclusion criteria

* Planned postoperative admission to the intensive care unit (ICU). * Social or psychiatric conditions that may interfere with compliance. * Isolation precautions. * Reconstruction, incisions, wounds, wound care, or injury that impact the ability to place on the VR headset or wear a Fitbit device around the wrist. * History of seizure or epilepsy. * History of vertigo or persistent dizziness. * Limitations that impair mobility. * Use of a walker or wheelchair at baseline.

Design outcomes

Primary

MeasureTime frameDescription
Mean daily opioid usethrough study completion, an average of 10 daysMean daily opioid use will be assessed converted into milligram morphine equivalents (MME).

Secondary

MeasureTime frameDescription
AnxietyBefore surgery and at study completion, an average of 10 daysThe Generalized Anxiety Disorder 7-Item scale (GAD-7) will be used to determine preoperative and postoperative level of anxiety. Cut points of 5, 10, and 15 may represent mild, moderate, and severe levels of anxiety.
DepressionBefore surgery and at study completion, an average of 10 daysThe Patient Health Questionaire-9 (PHQ-9) will be used to determine preoperative and postoperative level of depression. PHQ-9 scores can represent mild (\<4), moderate (5-14), and severe (\>20) depression.
Sleep QualityBefore surgery and at study completion, an average of 10 daysThe Insomnia Severity Index (ISI) will be used to determine preoperative and postoperative sleep quality. The ISI is a 7-item questionnaire evaluating severity of difficulty with sleep onset, sleep maintenance, early morning awakening, sleep dissatisfaction, interference in daytime functioning, noticeability of sleep difficulties by others, and distress from sleep difficulty. Items are rated on a 5-point Likert scale, and a total score ranges from 0 to 28.
Pain scoresthrough study completion, an average of 10 daysThe Numeric Rating Scale (NRS) from 0 to 10 will be used to determine pain scores collected in the morning and evening each day. Scores will be averaged to obtain the daily pain score. We will also look at differences between AM and PM pain scores among the different cohorts. Scores will range from 0 (no pain) to 10 (worst pain)
Disposition on dischargeat study completion, an average of 10 daysData regarding disposition on discharge to home, home with home health, skilled nursing facility, inpatient rehabilitation facility, or other facility will be determined from the electronic medical record on the day of discharge.
Length of hospital stayat study completion, an average of 10 daysLength of stay will be calculated beginning from postoperative day one and will include the day of discharge.
Patient experience and satisfactionat study completion, an average of 10 daysA Visual Analogue Scale (VAS) will used to analyze patient satisfaction during hospitalization, and will be provided to patients on day of discharge. The VAS is a horizontal line that is 100-mm long, with no satisfaction (0) on the very left and extreme satisfaction on the very right (100).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026